Cargando…
Discovery of Novel-Scaffold Monoamine Transporter Ligands via in Silico Screening with the S1 Pocket of the Serotonin Transporter
[Image: see text] Discovery of new inhibitors of the plasmalemmal monoamine transporters (MATs) continues to provide pharmacotherapeutic options for depression, addiction, attention deficit disorders, psychosis, narcolepsy, and Parkinson’s disease. The windfall of high-resolution MAT structural info...
Autores principales: | Nolan, Tammy L., Geffert, Laura M., Kolber, Benedict J., Madura, Jeffry D., Surratt, Christopher K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176318/ https://www.ncbi.nlm.nih.gov/pubmed/25003748 http://dx.doi.org/10.1021/cn500133b |
Ejemplares similares
-
Editorial: In silico Modeling of Brain Receptors for Antidepressants, Psychostimulants, and Other CNS-Active Drugs
por: Surratt, Christopher K., et al.
Publicado: (2016) -
Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
por: Bowman, Melodi A., et al.
Publicado: (2020) -
In Silico Investigations
into the Selectivity of Psychoactive
and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022) -
Involvement of Organic Cation Transporter-3 and Plasma Membrane Monoamine Transporter in Serotonin Uptake in Human Brain Vascular Smooth Muscle Cells
por: Li, Rachel W. S., et al.
Publicado: (2013) -
Methylone and Monoamine Transporters: Correlation with Toxicity
por: Sogawa, Chiharu, et al.
Publicado: (2011)